Timing of perinatal human immunodeficiency virus type 1 infection and rate of neurodevelopment
- 1 September 2000
- journal article
- research article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 19 (9) , 862-871
- https://doi.org/10.1097/00006454-200009000-00010
Abstract
Identifying HIV-1-infected children who are at greatest risk for disease-related morbidities is critical for optimal therapeutic as well as preventive care. Several factors have been implicated in HIV-1 disease onset and severity, including maternal and infant host characteristics, viral phenotype and timing of HIV-1 infection. Early HIV-1 culture positivity, i.e. intrauterine infection, has been associated with poor immunologic, virologic and clinical outcomes in children of HIV-infected women. However, a direct effect of timing of infection on neurodevelopmental outcome in infancy has not yet been identified. Serial neurodevelopmental assessments were performed with 114 infants vertically infected with HIV-1 in a multicenter natural history, longitudinal study. Median mental and motor scores were compared at three time points. Longitudinal regression analyses were used to evaluate the neurodevelopmental functioning of children with early positive cultures and those with late positive cultures. Early infected infants scored significantly lower than late infected infants by 24 months of age and beyond on both mental (P = 0.05) and motor (P = 0.03) measures. Early HIV-1 infection was associated with a decline in estimated motor scores of 1 standard score point per month compared with 0.28 point in the late infected group (P < 0.02). Estimated mental scores of the early infected group declined 0.72 point/ month, whereas the average decline of the late infected group was 0.30 point/month (P < 0.13). Early HIV-1 infection increases a child's risk for poor neurodevelopmental functioning within the first 30 months of life.Keywords
This publication has 35 references indexed in Scilit:
- Morbidity and Mortality in European Children Vertically Infected by HIV-1JAIDS Journal of Acquired Immune Deficiency Syndromes, 1997
- Impairment of Expressive Behavior in Pediatric HIV-Infected Patients with Evidence of CNS DiseaseJournal of Pediatric Psychology, 1996
- Dynamics of viral replication in infants with vertically acquired human immunodeficiency virus type 1 infection.Journal of Clinical Investigation, 1996
- Relationship between cognitive and immune functioning in children born to HIV‐1 seropositive womenDevelopmental Neuropsychology, 1996
- Effects of Pediatric HIV Infection and Prenatal Drug Exposure on Mental and Psychomotor DevelopmentJournal of Pediatric Psychology, 1994
- Adaptive Behavior of Children with Symptomatic HIV Infection Before and After Zidovudine TherapyJournal of Pediatric Psychology, 1994
- Replication and tropism of human immunodeficiency virus type 1 as predictors of disease outcome in infants with vertically acquired infectionThe Journal of Pediatrics, 1993
- Maternal Drug Use in Perinatal HIV Studies: The Women and Infants Transmission StudyaAnnals of the New York Academy of Sciences, 1993
- Perinatal infection by human immunodeficiency virus type 1 (HIV–1): Relationship between proviral copy number in vivo, viral properties in vitro, and clinical outcomeJournal of Medical Virology, 1991
- Effect of continuous-infusion zidovudine therapy on neuropsychologic functioning in children with symptomatic human immunodeficiency virus infectionThe Journal of Pediatrics, 1990